INTRODUCTION
Obesity results from complex interactions between environmental and genetic factors and is associated with a cluster of metabolic disorders such as hyperlipemia and diabetes and constitute risk factors for cardiovascular diseases (34) . Among environmental factors, a fatenriched diet, excessive calorie intake and a sedentary lifestyle increase this occurrence.
Obesity and associated metabolic disorders are also characterized by a chronic or so-called "low-grade" inflammation that is a risk factor for metabolic diseases (32) . Along with muscle and liver, the white adipose tissue (WAT) is an important tissue involved in several systemic processes such as glucose tolerance and inflammatory response via secretion of adipokines (73) . Several distinct inflammatory pathways are involved in the secretion of proinflammatory cytokines and chemokines, such as interleukin-6 (IL-6), interleukin-1 (IL-1) and monocyte chemotactic protein-1 (MCP-1), by WAT (57) . However, while the effects of inflammatory reactions on lipid metabolism and insulin resistance are known, the mechanisms contributing to the generation of low-grade inflammation remain to be elucidated.
In this respect, recent studies have shown that rodents fed a high-fat diet display alterations of gut microbiota that increase intestinal permeability (10) and gut inflammation (6) . Previous data in humans and rodents revealed that ~90 % of a normal gut microbiota is made of the Bacteroidetes and Firmicutes phyla, while obesity is linked to changes in their proportions (21, 31, 44, 80) . More recently, a link was revealed between high-fat diet, inflammation and the occurrence in plasma of pro-inflammatory products of Gram-negative bacteria of gut microbiota, namely lipopolysaccharides (LPS) so-called "endotoxins" (9, 10 ). The endotoxin metabolic pathway then includes the binding of LPS to LPS Binding Protein (LBP) and its subsequent transfer to the receptor CD14. Two forms of CD14 have been characterized: a membrane-bound glycoprotein (mCD14) and a circulating soluble form (sCD14) (29). LBP and sCD14 levels can be considered as relevant markers of endotoxins in plasma (30) . In this respect, given the long half-lives of sCD14 and LBP (24-48 hours) compared to endotoxin (from <8 min in mice to a maximum of 3 hours in humans), sCD14 and plasma LBP seem to reflect long-term exposure to endotoxin rather than the measurement of endotoxemia itself (49, 60) , which is more reliable to measure transient kinetics of endotoxin absorption (18, 39) .
Regarding the metabolic impact of these LPS transporters and receptors, LBP-bound LPS initiates inflammation via toll-like receptor-4 (TLR4) associated with mCD14 and induces the secretion of pro-inflammatory cytokines such as IL-6 that is involved in inflammation (67) . In septic shock high amounts of LBP inhibit LPS activity but low amounts of LBP in regular metabolic state are reported to increase LPS proinflammatory activity (38). Noticeably, sCD14 is reported to have suppressing effects on endotoxin activity by driving detoxification by HDL (70) . Interestingly however, fatty acids (FA) also bind TLR4 to induce proinflammatory cytokine expression in macrophages and adipocytes (66) .
Recent studies including ours showed that metabolic endotoxemia could be generated by gut LPS absorption during digestion of a high lipid load (4, 9, 18, 27, 39) . But none of these studies took into account the numerous dietary fat sources in Western diets and their FA profile that is suspected to affect the development of inflammatory response (5) . Therefore, the impact of oil fatty acid composition in Western-type diets on endotoxemia, LPS transporters and receptors and the onset of inflammatory outcomes deserves to be elucidated. Moreover, high fat diet studies in rodents used up to date regimen with >60% of energy as lard and devoid of carbohydrates (9, 11) ; therefore, the mechanisms associating dietary fat with endotoxin metabolism and inflammation deserves to be studied in more equilibrated fatrich regimen.
The aim of this study was thus to compare the effects of oils differing in fatty acid composition on endotoxin metabolism and inflammation in plasma and adipose tissue in the dynamic phase of weight gain and inflammation onset. Therefore, we tested animal diets based on chow enriched with different fat sources, i.e., milk fat, palm oil, rapeseed oil and sunflower oil. Because acute gavage studies had already been performed in previous studies (9, 18, 27, 39) , and short-duration diets can be unsufficient to observe inflammation, we chose to use a sufficient duration of 8 weeks to be able to induce the onset of metabolic inflammation that we aimed to compare with LPS receptors and endotoxemia. Animals and diets. Male C57Bl6/J mice (6 weeks, 18 g), were purchased from Harlan (Gannat, France) and kept at 24 ± 1 °C on a 12/12 h light cycle (light on from 06:00h to 18:00h) with a free access to food and tap water. Animals were housed at 4 per cage and adapted to the laboratory conditions for one week before beginning the experiment. Fat-rich diets were prepared by SAFE (Augy, France) and contained 22.4 % of lipids (Table 1) . Mice were randomly divided into 5 groups (n=8 per group) fed one of the 5 following diets during 8 weeks: a milk fat-enriched diet (MF), a palm oil-enriched diet (P), a rapeseed oil-enriched diet (R), a sunflower oil-enriched diet (S); a normal chow diet (Ch) was used as low-fat control (A04, SAFE, Augy, France). Fat-rich diets were thus especially designed to differ in oil composition only (76) and oils were chosen among the major dietary fats consumed worldwide (17) . Importantly, diets were manufactured using fats and oils for human consumption. Rapeseed and sunflower oil were from Lesieur (France), Palm oil was from SIO (Saint Laurent Blangy, France) and anhydrous milk fat was from Lactalis R&D (Retiers, France). Oils were therefore certified to be devoid of Gram negative bacteria; they were found non-pyrogenic using the LAL assay (no detectable endotoxemia). Moreover, diets produced by manufacturer (SAFE) passed all microbiological quality checks.
MATERIALS AND METHODS

Specific
Food intake was measured twice a week for 8 weeks and average food intake per day subsequently calculated. After 8 weeks under diet, mice were randomly sacrificed non-fasted during 4 days (2 mice per group per day) between 09:00h and 12:00h by intraperitoneal injection of pentobarbital. Blood was collected by cardiac puncture under pyrogen-free conditions on heparin-containing tubes. Plasma was obtained by centrifugation (8000 g, 10 min), frozen in liquid nitrogen and stored at -80°C until analysis. Small intestine mucosa, caecum contents, liver and white adipose tissue (WAT) corresponding to epididymal tissue, were collected, frozen in liquid nitrogen and stored at -80°C.
3T3-L1 cell culture and treatment. 3T3-L1 cells were obtained from the American Type
Culture Collection (ATCC, Manassas, VA, USA) and cultured at 37°C under 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM, Sigma), to which 10% fetal calf serum (BioWest), 4 mM L-Glutamine and antibiotics (Sigma) were added. Cell differentiation was performed in DMEM containing 5 µg/mL insulin (Actrapid 100UI/mL, Novo-Nordisk), 0. Limulus amoebocyte lysate (LAL) assays. Plasma endotoxemia (endotoxin unit per mL: EU/mL) was determined by using the limulus amoebocyte lysate (LAL) assay in kinetic chromogenic conditions (Biogenic, Pérols, France) as previously described (39) . Briefly, plasma sample was thawed and diluted 1/40 in pyrogen-free water (Biogenic), heated at 70°C for 10 min, subjected to an ultrasonic bath for 5 min and to a 1 min vortex. One hundred microliters of sample was combined with 100 µl LAL reagent (Chromolal, Biogenic) in triplicate in pyrogen-free 96-well plates (Biogenic). For each sample, a spiked control at 0.45 EU/mL was performed to check that no significant inhibition or activation occurred.
According to the FDA procedure, endotoxemia measurement is considered valid in these conditions if spike recovery is in the range 50-200% (75) , that is, 0.225-0.9 EU/mL greater than sample endotoxemia. In this study, spike recovery was in the range 95-124% (no significant differences among groups). Moreover, standard curve presented always regression coefficient of ~0.99 and the non-pyrogenicity of water was systematically checked. Data were analysed for endotoxemia calculation using the Softmax Pro software (Biogenic). mM NaCl, 5 mM EDTA, 0.5 mM Na 3 VO 4 , 50 mM NaF, 10 mg/L aprotinin, 10 mg/L leupeptin, 10 mg/L pepstatin and 1 mM PMSF). Fifty µg of proteins (8) were subjected to Western-blotting by separation using SDS-PAGE (10%) and transfer to polyvinylidine fluoride membrane. Membranes were blotted for TLR4 and tubulin (Santa Cruz Biotechnologies) using specific antibodies combined with HRP-conjugated anti-rabbit IgG antibody. Blots were developed using the ECL chemiluminescence method (GE Healthcare, Buckinghamshire, UK). Quantification was performed by densitometric analysis of specific bands on immunoblots using Quantity One software (BioRad).
Quantitative PCR analysis of caecal microbiota. Total bacteria DNA was extracted from 0.2 g of animal caecal material (n=3 per group) using the G'NOME kit (BIO 101, La Jolla, CA) with modifications as previously described (22). After the final precipitation, DNA was resuspended in 150 ml of TE buffer and stored at -20°C prior to further analysis.
The primers and probes used in this study, performed using an ABI 7000 Sequence Detection System with software version 1.2.3 (Applied Biosystems), were previously described (22).
TaqMan qPCR was adapted to quantify the total bacteria population in addition to the dominant (>1% of fecal bacteria) bacterial group; Clostridium leptum (C. leptum), Blautia Real-time qPCR using SYBR Green was performed for the subdominant bacterial group
Lactobacillus/Leuconostoc/Pediococcus group and for the species Escherichia coli (E. coli).
The TaqMan probes were synthesized by Applied Biosystems Applera-France (Courtaboeuf, France) and Primers were purchased from MWG (MWG-Biotech AG, Ebersberg, Germany).
Real-time qPCR was performed using an ABI 7000 Sequence Detection System with software performed using Student's t-test. Differences were considered significant at the P <0.05 level.
Principal component analysis was performed using JMP Software (version 9; SAS).
RESULTS
Lipid markers related to dietary fat composition in vivo.
Considering the reported importance of FA composition in food on metabolic inflammation, we studied different oils in high fat diets ( Table 1 ). The daily caloric intake of mice was similar among milk fat (MF), palm oil (P), rapeseed oil (R) and sunflower oil (S) groups (data not shown). The body weight, the liver and the white adipose tissue (WAT) weights of the MF group were significantly higher than in mice of the other groups (P<0.001 or P<0.05, Table 2 ); MF and R gained more weight than Ch. The profile of total FA in WAT (Table 2 ) reflected the composition of ingested dietary fats (Table 1) . Arachidonic acid (20:4 n-6), an n-6 FA precursor of proinflammatory derivatives in biological membranes, was similar in the phospholipids (PL) of WAT in all high-fat groups ( Table 2 ). The global n-6/n-3 ratio, reflecting increased risk of inflammation derived from PUFA metabolites, was lower in WAT-PL of R group than other high-fat groups (not different from Ch group), and higher in WAT-PL of S group. However, n-6/n-3 ratio was not different in WAT-PL of MF, P and Ch groups. Moreover, palmitate content in plasma lipids was similar in Ch, MF and P group on the one hand, and in S and R groups on the other hand ( Table 2 ). Figure 1A shows that the plasma TAG concentration was higher in the MF group than in the P and S groups. Moreover, P, R and S group presented lower plasma TAG than Ch group. However, plasma NEFA were similar among all groups ( Figure 1B) .
Markers of inflammation and of metabolic endotoxemia in plasma are modified by dietary fat
composition. Regarding inflammation, the P diet led to a higher concentration in plasma of the inflammatory cytokine IL-6 than in other groups( Figure 2A ). The P diet was also the only high fat diet to result in higher concentration in plasma of MCP-1 than Ch (194.4 ±39.9 vs 101.4 ±40.1 pg/mL; P<0.05). Overall, the P group was thus the only high-fat group to induce significantly higher inflammation in plasma than Ch group after 8 weeks (P<0.05).
We then measured different circulating transporters and receptors in plasma that are involved in the pro-inflammatory potential of endotoxins, namely, LBP and sCD14. Among high-fat groups, only the P group presented higher LBP than Ch group (P<0.01) ( Figure 2B ). LBP was also higher in P group than in other high-fat groups. Strikingly, in mice of the P group, plasma IL-6 levels were even highly correlated with plasma LBP levels (P<0.003, Figure 2C ). The highest concentration of sCD14 was observed in the R group ( Figure 2D ) compared with MF, P and S groups (P<0.05). Moreover, Figure 2E shows that the P group had the highest LBP/sCD14 ratio compared with all other groups including Ch (P<0.01); this P group also exhibited the greatest pro-inflammatory profile. This higher LBP/sCD14 ratio indicates a higher ability for plasma LPS to be vehicled to target tissues in the P group than in other groups. In contrast, MF, R, S and Ch groups presented both similar LBP/sCD14 ratios and similar IL-6 levels in plasma, lower than the P group.
Parallel to these differences in LPS transport ability, we also measured plasma endotoxemia by the LAL assay. As shown Figure 2F , mice fed the unsaturated FA diets tended to present a higher plasma endotoxemia than mice fed the saturated FA diets. The highest plasma endotoxemia measured by LAL assay was actually detected in the R group (P<0.01 vs Ch, MF and P groups).
Markers of inflammation and endotoxin receptors in epididymal adipose tissue are modified
by dietary fat composition. In WAT, expression of proinflammatory cytokine IL-1 that is produced both by adipocytes and macrophages was significantly higher in P group compared with all other groups (P<0.05, Figure 3A) . Interestingly, expression of LPS-receptor CD14 was higher in the WAT of P group compared with all other groups including Ch (P<0.01) ( Figure 3B ). Moreover, the LPS receptor TLR4 was significantly enhanced in the WAT of P group in comparison with other groups as revealed both by Western Blotting ( Figure 3C ) and mRNA expression ( Figure 3F ). IL-6 that is expressed in macrophages was on the whole few expressed in WAT ( Figure 3D ). The global marker of macrophage infiltration CD68 tended to be more expressed in several high fat groups, namely P, R and S ( Figure 3E ).
These results show that the high-fat diet containing palm oil induced the highest amounts of inflammatory markers in plasma and highest expression of IL-1, TLR4 and CD14 in WAT.
The milk-fat diet resulted in a lower inflammatory profile than the palm oil diet, while similarly rich in saturated FA but containing medium chain fatty acids (Table 1) . Moreover, MF, R and S diets resulted in similar plasma levels of MCP-1, IL-6 and of IL-1, TLR4 and CD14 expression in WAT, not significantly different from Ch.
Altogether, the results suggest that mice fed a high-fat diet enriched with palm oil for 8 weeks presented a more active gut-derived endotoxin transport oriented towards inflammation than diets enriched with milk fat, rapeseed oil or sunflower oil. This could explain the higher circulating pro-inflammatory cytokine with the palm oil diet and higher WAT inflammation. To test whether gut LPS could be partly absorbed by enterocytes, imaging was performed in the jejunum in high-fat fed mice. Electronic microscopy using an anti-LPS antibody revealed the presence of such LPS in enterocytes of the jejunal section, the major area of lipid absorption, regardless of the high fat group ( Figure 5 ). These data indicate that FA were able to participate in induced inflammation in adipocytes in vitro, either alone or synergistically with endotoxins.
Endotoxemia could originate from LPS
DISCUSSION
The novel feature of the present study is that it focuses on the effects of dietary oil composition on LPS-related inflammation, an aspect that has thus far been widely ignored.
This is an important issue for human nutrition because in Western diets, vegetable oils including palm oil are increasingly widely used conversely to animal fats such as milk fat (2, 19 Our results show that depending on oil composition in the diet, inflammation and endotoxin transporters were modulated differently. We showed in vitro that palmitic acid elicited the most important effect on IL-6 secretion by adipocytes, even if acute in vitro effects cannot reflect in vivo mechanisms. Moreover, we showed in vivo that the palm-oil enriched diet induced higher IL-6 than other diets including chow. This is consistent with epidemiological observations suggesting a positive association between diet and plasma IL-6 concentrations (5). Inflammation onset was not correlated with body weight gain. The n-6 FA are reported to be pro-inflammatory while n-3 FA are anti-inflammatory (28, 61) . However in this study, the FA status in WAT-PL did not appear to contribute to plasma and WAT inflammation neither:
indeed, no differences were observed for the percentage of arachidonic acid between the 4 groups and the ratio n-6/n-3 FA was not correlated with the measured markers of circulating and WAT inflammation. Also, palmitate concentration in plasma was not correlated with inflammation as circulating palmitate was similar in P, MF and Ch groups. Moreover, when LPS was added to FA in vitro, we observed the highest IL-6 production for palmitic and -linolenic acids. These results support the concept of a synergistic action of LPS and fatty acids on the secretion of pro-inflammatory cytokines.
We further investigated in vivo endotoxin metabolism depending on dietary oil composition.
Indeed, pro-inflammatory LPS have been reported to be able to diffuse from the gut to the bloodstream during high fat diets, either by direct diffusion through intestinal paracellular permeability and/or through absorption by enterocytes during chylomicron secretion (10, 27, 39) . In this study, the presence of LPS inside jejunal enterocytes was indeed detected by electronic microscopy in all groups.
In this context, LBP and sCD14 appear to be key players in determining the inflammatory response to plasma LPS exposure. LBP and sCD14 are reported to function as molecules that shuttle LPS, having both activatory and suppressive effects via mCD14 activation and HDLmediated clearance, respectively (35, 70) . Very recently, a higher LBP/sCD14 ratio has been observed in patients suffering from gut-derived inflammation compared with controls (37).
LBP is actually increasingly used as a marker of metabolic endotoxemia in clinical and rodent studies (43, 53, 56, 64, 69) , because it is a major pro-inflammatory LPS transporter in plasma.
In our study, the P group was the only group to present significantly higher LBP compared with Ch and higher than other high fat groups. Moreover, in P group, a strong correlation was observed between plasma LBP and plasma IL-6. Moreover, The P group was also the only one to present higher inflammation in plasma and IL-1, TLR4 and CD14 expression in WAT compared with Ch. Consistently, we highlight that mice of the P group also had a greater LBP/sCD14 ratio than mice fed other diets. LBP is an acute-phase protein (72) whose plasma concentration increases during inflammation (23) and that delivers circulating LPS to CD14
or HDL (67) . During an acute inflammatory response the LBP/sCD14 ratio is known to increase (67) . Moreover, the binding of LPS to LBP-sCD14 conducts to the activation of proinflammatory cells via TLR4 pathway that result in production of pro-inflammatory markers including IL-6 and IL-1. The LPS thus induce a higher inflammatory reaction when bound to LBP than in free unbound form (48, 71) . Moreover, we cannot rule out the possibility that LBP increase in P group was secondarily enhanced due to sensitivity to overall inflammatory status: IL-6 and IL-1 are indeed reported to induce the expression of LBP by airway epithelial cells (63) and IL-22 induces LBP in hepatocytes (78).
In turn, sCD14 recently appeared to provide protective effects against LPS response (20, 79 ).
An excess of sCD14 in plasma is actually reported to buffer the inflammatory signals, avoiding LPS exposure with cell-anchored mCD14 (20) . In mice, Fernandez-Real recently revealed that treatment with recombinant human sCD14 improves glucose tolerance following a high fat diet and decreases IL-1 expression in epididymal WAT (20) . Similarly in the present study, high sCD14 in R group was associated with low IL-1 expression in WAT. In humans, the administration of sCD14 is now suggested as a therapeutic strategy to ameliorate phenotypes associated with the metabolic syndrome (20) . Also, the increased ability of plasma to eliminate endotoxins by sCD14 after gastrointestinal surgery was reported to be more important than endotoxemia itself in patient clinical outcome; besides, sCD14 levels were beneficially increased by using a nutritional strategy in these patients to improve their clinical outcome (79) . Altogether in our study using dietary lipid modifications, we observe that the lower inflammation of R group compared with P group is associated with significantly higher sCD14 in R group despite apparently elevated metabolic endotoxemia.
In our diets, plasma endotoxemia was not associated with fat content in the diet (22% vs 3%) but rather with lipid quality, plasma endotoxemia being on the whole higher in unsaturated R and S groups. In the literature, Amar et al. have shown that plasma endotoxemia was lower after control diet (~2 EU/mL) compared with 35% fat/37% carbohydrate/28% protein diet (~3 EU/mL) or high fat (72%)/high protein (28%) diet (~6 EU/mL) (4). Cani et al. reported higher plasma endotoxemia in high-fat (in the range 5-10 EU/mL) vs chow diet (<5 EU/mL) (9, 11, 14) . Importantly, these authors used high fat diets very different from the present study, i.e, up to 72% energy as fat and almost devoid of carbohydrates (9, 10, 12, 13) . In contrast, our diets contained 38% energy as fat and the non-fat components were balanced using chow ingredients. The latter include wheat and barley that can contain non-digestible fermentable carbohydrates reported to be beneficial for the gut barrier and to lower endotoxemia (11).
Because all our diets contained the same amount of such carbohydrates, our results suggest that oil composition in the diet may modulate their endotoxemia-lowering effects.
However, importantly, plasma endotoxemia is transient in nature with a reported half-life of LPS in plasma of only <8 minutes (49) because of LPS uptake by various receptors and transporters in plasma (18, 39) . In sepsis, the severity of inflammatory reaction cannot be correlated to the blood levels of endotoxins (33) . Indeed, endotoxins do not have to be necessarily detected in blood to confirm that endotoxins have been absorbed into blood, mainly because plasma endotoxemia fluctuates during the day and during digestion (11, 18, 26, 39). Moreover, even using great caution such as sample heating, there are known difficulties in removing interference in blood regarding endotoxemia analysis (59) . According to Sun et al. (69) , the short half-life of LPS and the disadvantages associated with the LAL assay have limited its potential applications in routine clinical settings and large-scale studies.
Therefore, the observed differences in plasma endotoxemia between the R group and other groups in this study may have been enhanced by a combination of (i) diurnal variations in detectable LPS concentrations, (ii) different digestion times at the moment of sacrifice and blood sampling. Indeed, mice were sacrificed in the fed state to be in the phase of intestinal lipid absorption where acute LPS absorption had been described (18, 27, 39) . Conversely, having a relatively long half-life and reliable measurements, LBP might serve as a marker reflecting an "effective" LPS level and innate immune response triggered by LPS (69) . As such, LBP is reported to be a marker better reflecting long-term exposure to endotoxins rather than plasma endoxemia itself (18, 33, 60, 69) .
Altogether, our observation of different LBP/sCD14 ratios after different high fat diets is an indicator of specific metabolic adaptations to circulating endotoxin transport that can either efficiently trigger inflammation (high LBP in P group) or prevent inflammation (high sCD14 in R group). The different inflammation profiles between R and P groups may be due to the different impacts of these diets on the ability of plasma to bind endotoxins with a more important contribution of sCD14 compared with LBP for the R group. Importantly, elevated plasma levels of LBP have recently been reported to be associated with obesity, metabolic syndrome, type 2 diabetes and cardiovascular mortality in humans (43, 69) . Therefore, our results support such a role of LBP in metabolic disorders, which could be modulated by the quality of dietary fats and oils.
Consistently with LBP plasma levels, we show that TLR4 and CD14 expression in epididymal adipose tissue were the highest following the palm-rich diet. This result suggests that WAT of the P group was more able to respond to circulating LPS by favouring the transduction of the inflammatory signal. It is important to note that (i) TLR4 and CD14 expression in WAT are modulated depending on oil composition of the diet and (ii) this profile of TLR4 and CD14 expression in WAT among the different groups is similar to the plasma IL-6 profile.
The observed difference in plasma IL-6 depending on the dietary oil composition can be explained by different mechanisms. Firstly, the ability of long-chain saturated FA to trigger inflammation via TLR4 was already shown in vitro (16, 66, 68, 74) . Actually, TLR4 is known to be a potential candidate to initiate inflammation and insulin resistance via its activation by fatty acids (3, 40, 66) . In this study however, palmitic acid alone cannot explain differences in inflammation via TLR4 activation because plasma palmitate levels were not higher in P group compared with Ch and MF groups. Thus, evidence converges on the possibility that both FA and LPS can activate TLR4 and trigger inflammation in different tissues. Secondly, in vitro results show that differences in IL-6 release by adipose cells may be provoked by a synergistic action of LPS and FA. However, in vivo, differences of WAT inflammatory status were observed regarding IL-1 while IL-6 expression was modest, certainly because IL-6 is mostly expressed in macrophages that are diluted in WAT. Therefore, elevated plasma IL-6 in P group cannot be directly explained by IL-6 production by WAT. However, it may be due to an indirect effect of IL-1 that is secreted by WAT on the secretion of IL-6 by the liver (47).
Finally, we cannot rule out a possible contribution of gut microbiota on plasma inflammatory markers. Indeed, the literature shows that pro-inflammatory high-fat diets induce intestinal dysbiosis in C57Bl6/j mice, though with discrepancies such as decreased Bacteroides after 4 weeks (58) or increased Bacteroides after 12 weeks (62) using the same high fat diet plasma endotoxemia and inflammation (11), however, this genus was undetectable in the presently studied mice. Altogether, considering the different reported effects of high fat diets on gut microbiota, we raise the question of whether not only the amount but also the biochemical composition and biological activity of gut-derived LPS would be modified by the diet; this should be the subject of further studies.
Importantly, lipid metabolism is now recognized to interact with endotoxemia. Apart from endotoxin receptors characterized in the present study, HDL are also reported to contribute to LPS clearance from plasma (67, 70) . It would thus be interesting to conduct studies on interactions between plasma lipoprotein metabolism and LPS receptors after different high fat diets. Moreover, as discussed above, plasma endotoxemia varies according to the feeding status of mice and chylomicrons contribute to LPS transport in plasma. In the present study, plasma has been characterized in the fed state. In order to gain deeper knowledge of fasting and postprandial endotoxemia according to the diet, further studies should aim at measuring fasting and postprandial endotoxin metabolism after oil gavage following different high fat diets. Dose-response designs for the different high fat diets would also allow to conclude on the relative impact of fat composition and fat content on metabolic inflammation related to endotoxin receptors.
In humans, epidemiological and intervention studies often discuss that inflammation-related cardiovascular diseases would be positively related to consumption of SFA and negatively to consumption of PUFA (1, 7, 15, 65, 77) . However, recent data show that (i) substituting SFA with carbohydrates is unefficient or even deleterious regarding CVD risk (50, 54) so that the quality of fat (saturated FA vs PUFA) should be discussed on an isolipidic basis and (ii) SFA correspond to different individual molecular species including short and medium chain FA whose health effects should be considered independently (42, 50) . Both the isolipidic design and existing differences in SFA chain length in saturated fats (MF, P) were accounted for in the present study. Noticeably, medium-chain triglycerides were shown to protect rats from LPS-induced injury of gut and liver, contrary to corn oil (36) . Moreover, saturated fat structure can be very different among fats and oils, including FA position on the triglycerides (51, 55) . In this respect, we must note that a greater inflammation was observed with the palm oil diet compared with the milk-fat diet. This indicates that low-grade inflammation induced by FA and endotoxin transport by LBP and sCD14 is not a common characteristic of all SFA but specific of each fat composition. Moreover, rapeseed oil, sunflower oil and milk fat were found to result in similar plasma levels of pro-inflammatory cytokine, despite their different FA and TAG structures, which was associated with similar LBP/sCD14 ratio. Importantly, rapeseed oil is rich in alpha-linolenic acid (ALA). This n-3 PUFA is described to present beneficial metabolic effects to prevent low-grade inflammation (61) . The present results suggest a new beneficial effect of ALA-rich oils that can enhance plasma sCD14 and thus may buffer LPS and lower inflammatory response.
In conclusion, we demonstrate that compared with milk fat, rapeseed oil or sunflower oil, a high-fat diet formulated with palm oil results in higher inflammation in plasma and adipose tissue and a higher circulating LBP/sCD14 ratio reflecting proinflammatory endotoxin transport. In contrast, rapeseed oil resulted in lower inflammation through higher levels of sCD14 despite elevated endotoxemia. Therefore, the onset of high-fat-diet induced inflammation in mice appears to depend on dietary fat composition, partly through plasma endotoxin receptors and transporters sCD14 and LBP oriented towards TLR4 and CD14 activation rather than being directly correlated with gut-derived plasma endotoxemia.
Nutritional strategies can thus be envisaged by optimizing dietary lipid sources in order to blunt the metabolic path involving endotoxin transport that contributes to low-grade inflammation in metabolic diseases.
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